Dr. Sharief Taraman, MD, DABPN, DABPM, FAAP, is CEO of Cognoa, a leading early childhood development & pediatric behavioral health company. Neurodevelopment refers to the brain’s growth and maturation ...
Researchers identified a protein in mouse models that acts as a brake on myelin production, which could be a target for new MS treatments.
A special issue of the Journal of Pediatric Rehabilitation Medicine aims to deepen the conversation around one of the most common developmental movement disorders in children Co-guest editor Michael ...
There’s a lot to consider when treating ADHD, including which different ADHD meds are commonly prescribed to kids — and why. Attention deficit hyperactivity disorder (ADHD) is one of the most common ...
NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for ...
Advanced AI-driven therapies transform the landscape of brain health and neurodevelopmental treatment. Cosmos Healthcare, a leader in innovative health solutions, is proud to launch two groundbreaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback